The good and bad of microglia/macrophages: New hope in stroke therapeutics

Acta Pharmacologica Sinica

Volumn 34, Issue 1, 2013, Pages 6-7

  Huang, Ya Chi ^a   Feng, Zhong Ping ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CEREBROVASCULAR ACCIDENT; HUMAN; INFLAMMATION; MACROPHAGE; MICROGLIA; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE;

EID: 84872082423     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.178     Document Type: Article

References (7)

1. Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem 2012;123 Suppl 2:29-38.
2. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67:181-98.
3. Sughrue ME, Mehra A, Connolly ES Jr, D'Ambrosio AL. Anti-adhesion molecule strategies as potential neuroprotective agents in cerebral ischemia: a critical review of the literature. Inflamm Res 2004;53:497-508. (Pubitemid 40110114)
4. Marler JR, Goldstein LB. Medicine. Stroke - tPA and the clinic. Science 2003;301:1677.
5. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004;24:945-63. (Pubitemid 39223619)
6. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia/Macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012;43:3063-70.
7. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010;6:193-201.